Drawing for IPHRONESIS

USPTO serial 87464806

IPHRONESIS

Reviewed by CopyMark Law Group

Reg. 5405398Status 710
Filing date
Status date
Registration date
Feb 20, 2018
Examiner
SHANOSKI, JOANNA MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with IPHRONESIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable Machine learning-based, knowledge automation analytics software; Computer software platforms for providing a machine learning-based, knowledge automation analytics; Computer software platforms for providing a machine learning-based, knowledge automation analytics in the fields of life sciences and healthcare; Computer software recorded on computer media for integrating research and diagnostics across data sources in the field of medicine; Downloadable computer software for generating structured corpora; Downloadable computer software for generating structured corpora in the fields of life sciences and healthcare; Computer software recorded on data media for designing and deploying workflows; Computer software recorded on data media for designing and deploying workflows in the fields of life sciences and healthcare; Downloadable computer software for searching on line for biomedical entities and contacting found entities; Downloadable computer software for variant analysis and reporting in the field of bioinformatics; Downloadable Computer bioinformatics software for variant analysis and reporting in the fields of life sciences and healthcare; Computer software recorded on data media for converting disparate unstructured data into a structured form; Computer software recorded on data media for mapping custom variant curation schemas to data found in large corpora; Computer software recorded on data media for generating visualizations of datasets; Computer software recorded on data media for generating visualizations of datasets in the fields of life sciences and healthcare; Computer software for identifying novel genetic variants and genotype-phenotype relationships, and providing relevancy scores; Downloadable computer software for developing personal treatment strategies for patients with diagnosed cancer, patients with hereditary diseases, patients with pre-disposition to a possible genetic disorder, patients with neurological diseases such as Alzheimer's or Dementia, patients with cardiac diseases, and patients with diseases for treatment by microbiome based therapeutic treatments; Downloadable computer software for developing personal treatment strategies using patient demographics, clinical data, and genetic factors including drug metabolism, drug response, and drug toxicity for patients with diagnosed cancer, patients with hereditary diseases, patients with pre-disposition to a possible genetic disorder, patients with neurological diseases such as Alzheimer's or Dementia, patients with cardiac diseases, and patients with diseases for treatment by microbiome based therapeutic treatmentsSECTION 8 - CANCELLEDJan 1, 2015
042Providing temporary use of on-line, non-downloadable machine learning-based, knowledge automation analytics software; Platform as a service (PAAS) featuring computer software platforms for providing a machine learning-based, knowledge automation analytics; Platform as a service (PAAS) featuring computer software platforms for providing a machine learning-based, knowledge automation analytics in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for integrating research and diagnostics across data sources in the field of medicine; Providing temporary use of on-line, non-downloadable software for generating structured corpora; Providing temporary use of on-line, non-downloadable software for generating structured corpora in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for designing and deploying workflows; Providing temporary use of on-line, non-downloadable software for designing and deploying workflows in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for searching on line for biomedical entities and contacting found entities; Providing temporary use of on-line, non-downloadable software for variant analysis and reporting in the field of bioinformatics; Providing temporary use of on-line, non-downloadable bioinformatics software for variant analysis and reporting in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for converting disparate unstructured data into a structured form; Providing temporary use of on-line, non-downloadable software for mapping custom variant curation schemas to data found in large corpora; Providing temporary use of on-line, non-downloadable software for generating visualizations of datasets; Providing temporary use of online, non-downloadable software for generating visualizations of datasets in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for identifying novel genetic variants and genotype-phenotype relationships, and providing relevancy scores; Providing temporary use of on-line, non-downloadable software for developing personal treatment strategies for patients with diagnosed cancer, patients with hereditary diseases, patients with pre-disposition to a possible genetic disorder, patients with neurological diseases such as Alzheimer's or Dementia, patients with cardiac diseases, and patients with diseases for treatment by microbiome based therapeutic treatments; Providing temporary use of on-line, non-downloadable software for developing personal treatment strategies using patient demographics, clinical data, and genetic factors including drug metabolism, drug response, and drug toxicity for patients with diagnosed cancer, patients with hereditary diseases, patients with pre-disposition to a possible genetic disorder, patients with neurological diseases such as Alzheimer's or Dementia, patients with cardiac diseases, and patients with diseases for treatment by microbiome based therapeutic treatmentsSECTION 8 - CANCELLEDJan 1, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 30, 2024C8..CANCELLED SEC. 8 (6-YR)—
Feb 20, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 20, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 5, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 5, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 27, 2017ALIEASSIGNED TO LIE—
Oct 11, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 5, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 4, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 4, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 24, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2017DOCKASSIGNED TO EXAMINER—
Jun 2, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 29, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance